AFP and hepatocellular carcinoma: In biopsy-proven HCC patients, the malignant score demonstrated superior accuracy than AFP (cutoff of 20 ng ml−1) in differentiating HCC patients from non-cancerous individuals (AUC 0.957 versus 0.803, Fig. 4A, B).